These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 2661139)
1. Role of eicosanoids as mediators of glomerular injury in immune-mediated nephropathies. Zoja C; Benigni A; Remuzzi G Contrib Nephrol; 1989; 69():18-26; discussion 37-8. PubMed ID: 2661139 [No Abstract] [Full Text] [Related]
2. Eicosanoids and platelet-activating factor in allergic respiratory diseases. Henderson WR Am Rev Respir Dis; 1991 May; 143(5 Pt 2):S86-90. PubMed ID: 1902069 [TBL] [Abstract][Full Text] [Related]
3. Eicosanoids and renal allograft rejection. Wardle EN Nephron; 1995; 70(2):151-4. PubMed ID: 7566297 [TBL] [Abstract][Full Text] [Related]
4. Role of lipid mediators and control of lymphocyte responses in type 2 immunopathology. Samuchiwal SK; Boyce JA J Allergy Clin Immunol; 2018 Apr; 141(4):1182-1190. PubMed ID: 29477727 [TBL] [Abstract][Full Text] [Related]
5. Interaction of eicosanoids and macrophages during inflammatory responses. Rogers TS; Smith EF; Wise WC; Halushka PV; Cook JA Surv Immunol Res; 1984; 3(2-3):161-4. PubMed ID: 6718845 [No Abstract] [Full Text] [Related]
6. Eicosanoids: an emerging role in dendritic cell biology. Harizi H; Gualde N Arch Immunol Ther Exp (Warsz); 2004; 52(1):1-5. PubMed ID: 15053227 [TBL] [Abstract][Full Text] [Related]
7. Eicosanoids and organ transplantation. Foegh ML; Alijani MR; Helfrich GB; Ramwell PW Ann Clin Res; 1984; 16(5-6):318-23. PubMed ID: 6442847 [No Abstract] [Full Text] [Related]
8. Urinary prostaglandins and thromboxane in patients with chronic glomerulonephritis. Niwa T; Maeda K; Shibata M Nephron; 1987; 46(3):281-7. PubMed ID: 3627322 [TBL] [Abstract][Full Text] [Related]
10. Prostaglandins & other lipid mediators: a new phase, a new team. Hla T Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):1-2. PubMed ID: 15165026 [No Abstract] [Full Text] [Related]
11. Role of leukotrienes and lipoxygenases in glomerular injury. Nassar GM; Badr KF Miner Electrolyte Metab; 1995; 21(4-5):262-70. PubMed ID: 7565475 [TBL] [Abstract][Full Text] [Related]
12. Significance of myocardial eicosanoid production. van Bilsen M; Engels W; van der Vusse GJ; Reneman RS Mol Cell Biochem; 1989 Jun 27-Jul 24; 88(1-2):113-21. PubMed ID: 2674662 [TBL] [Abstract][Full Text] [Related]
14. Regulatory interactions between inducible nitric oxide synthase and eicosanoids in glomerular immune injury. Lianos EA; Guglielmi K; Sharma M Kidney Int; 1998 Mar; 53(3):645-53. PubMed ID: 9507210 [TBL] [Abstract][Full Text] [Related]
15. Eicosanoids and platelet activating factor mechanisms in organ rejection. Foegh ML Transplant Proc; 1988 Dec; 20(6):1260-3. PubMed ID: 3059615 [TBL] [Abstract][Full Text] [Related]
16. The role of eicosanoids in human glomerular disease. Pierucci A; Cinotti GA Adv Exp Med Biol; 1989; 259():389-421. PubMed ID: 2696358 [No Abstract] [Full Text] [Related]